Middle East and Africa Cervical Cancer Diagnostic Testing Market Developments by 2028
Middle East and Africa Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)
- Report Date : Mar 2022
- Report Code : TIPRE00027458
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 127
The MEA cervical cancer diagnostic testing market is expected to grow from US$ 218.90 million in 2021 to US$ 282.38 million by 2028; it is estimated to grow at a CAGR of 3.7% from 2021 to 2028.
The cervical cancer diagnosis test market players focus on launching new products to expand their geographic reach and enhance capacities to cater to a greater than existing customer base. In November 2021, Hologic, Inc. launched the Genius Digital Diagnostics System for cervical cancer screening. Next-generation screening systems combine deep earning-based artificial intelligence (AI) with the latest volumetric imaging technology to assess precancerous lesions and cervical cancer cells in women. Similarly, in 2019, BD’s COR PX/GX system was launched, which is available in centralized labs across region since 2019 to assist in high-volume processing and increase overall efficiency. Similarly, one popular government insurance program provides cover for PAP tests, pelvic exams, and clinical breast examinations performed every two years for cervical cancer screening. Such programs and developments and launches of new products are likely to bring new trends in the MEA cervical cancer diagnosis test market in the coming years, thereby supporting its growth.In case of COVID-19, MEA is highly affected especially South Africa. The healthcare sector in the UAE has undergone a considerable number of infrastructure and procedural changes to position itself as a leading healthcare provider. These improvements have been more recently recognized throughout the COVID-19 pandemic due to the continuous investments made to improve the sector’s hard and soft infrastructure. However, COVID-19 is likely to continue to have a notable impact on healthcare operations in countries. The pandemic had a major impact on a wide range of health outcomes. Disordering of elective health services related to cervical screening, management of abnormal screening test results, and treatment of pre-cancers, that lead to increase in cervical cancer incidence and inflame existing health disproportions. Since, the beginning of 2020, the pandemic has caused enormous health, social and economic impacts, likely to continue in 2021. Even after some of these impacts have been mitigated or contained, there will be medium and longer-term consequences. In many countries, diagnostics services have been disrupted, and supply chains for key commodities have been stretched. In Africa, COVID-19 has threatened the control of major health conditions including cervical cancer. As COVID-19 continues to spread in Africa, there are concerns over its impact on market, limited diagnosis, and decreased access to expert gynecologists further impacting the market in the region. However, as the pandemic situation overcomes, the demand for several diagnostics modalities used in cervical cancer diagnosis will increase. With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA cervical cancer diagnostic testing market. The MEA cervical cancer diagnostic testing market is expected to grow at a good CAGR during the forecast period.
MEA Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
MEA Cervical Cancer Diagnostic Testing Market Segmentation
MEA Cervical Cancer Diagnostic Testing Market – By Type
- PAP Testing
- HPV Testing
- Colposcopy
- Cervical Biopsies
- Cystoscopy
- Others
MEA Cervical Cancer Diagnostic Testing Market – By Service Provider
- Diagnostics and Research Laboratories
- Hospitals and Clinics
- Specialty Clinics
- Home Care Services
MEA Cervical Cancer Diagnostic Testing Market, by Country
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
MEA Cervical Cancer Diagnostic Testing Market - Companies Mentioned
- Abbott
- BD
- Cooper Companies, Inc.
- F. Hoffmann-La Roche Ltd.
- Femasys Inc.
- Guided Therapeutics, Inc
- Hologic, Inc.
- QIAGEN
- Quest Diagnostics Incorporated
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Cervical Cancer Diagnostic Testing Market – By Type
1.3.2 MEA Cervical Cancer Diagnostic Testing Market – By Service Provider
1.3.3 MEA Cervical Cancer Diagnostic Testing Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Cervical Cancer Diagnostic Testing Market – Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Cervical Cancer Diagnostic Testing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Cervical Cancer
5.1.2 Escalating HPV Infections
5.2 Market Restraints
5.2.1 Deficiency of Awareness about the Diagnosis and Treatment Methods
5.3 Market Opportunities
5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Rising Development and Launch of Innovative Products
5.5 Impact Analysis
6. Cervical Cancer Diagnostic Testing Market – MEA Analysis
6.1 MEA Cervical Cancer Diagnostic Testing Market Revenue Forecast and Analysis
7. MEA Cervical Cancer Diagnostic Testing Market Analysis – By Type
7.1 Overview
7.2 MEA Cervical Cancer Diagnostic Testing Market, By Type, 2021 & 2028 (%)
7.3 PAP Testing
7.3.1 Overview
7.3.2 PAP Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
7.4 HPV Testing
7.4.1 Overview
7.4.2 HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Colposcopy
7.5.1 Overview
7.5.2 Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Cervical Biopsies
7.6.1 Overview
7.6.2 Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
7.7 Cystoscopy
7.7.1 Overview
7.7.2 Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
8. MEA Cervical Cancer Diagnostic Testing Market Analysis – By Service Provider
8.1 Overview
8.2 MEA Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)
8.3 Diagnostics and Research Laboratories
8.3.1 Overview
8.3.2 Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Hospitals and Clinics
8.4.1 Overview
8.4.2 Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Specialty Clinics
8.5.1 Overview
8.5.2 Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)
8.6 Home Care services
8.6.1 Overview
8.6.2 Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Cervical Cancer Diagnostic Testing Market – Country Analysis
9.1 MEA: Cervical Cancer Diagnostic Testing Market
9.1.1 Overview
9.1.2 MEA: Cervical Cancer Diagnostic Testing Market, by Country, 2021 & 2028 (%)
9.1.2.1 Saudi Arabia: Cervical Cancer Diagnostic Testing Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.1.1 Saudi Arabia: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2 Saudi Arabia Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.2.1.3 Saudi Arabia: Cervical Cancer Diagnostic Testing Market, by Service Provider, 2019–2028 (USD Million)
9.1.2.2 UAE: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 UAE: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2 UAE Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.2.2.3 UAE: Cervical Cancer Diagnostic Testing Market, by Service Provider, 2019–2028 (USD Million)
9.1.2.3 South Africa: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 South Africa: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2 South Africa Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)
9.1.2.3.3 South Africa: Cervical Cancer Diagnostic Testing Market, by Service Provider, 2019–2028 (USD Million)
9.1.2.4 Rest of MEA: Cervical Cancer Diagnostic Testing Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.4.1 Rest of MEA: Cervical Cancer Diagnostic Testing Market - Revenue and Forecast to 2028 (USD Million)
9.1.2.4.2 Rest of MEA Cervical Cancer Diagnostic Testing Market, by Vaccines Type– Revenue and Forecast to 2028 (USD Million)
9.1.2.4.3 Rest of MEA: Cervical Cancer Diagnostic Testing Market, by Service Provider, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on MEA Cervical Cancer Diagnostic Testing Market
10.1 MEA: Impact Assessment of COVID-19 Pandemic
11. MEA Cervical Cancer Diagnostic Testing Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Abbott
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Quest Diagnostics Incorporated
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 QIAGEN
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hologic, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Femasys Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Guided Therapeutics, Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Cooper Companies, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 BD
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Veterinary Vaccines Market, by Service Provider – Revenue and Forecast to 2028 (USD Million)
Table 4. UAE Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 5. UAE Cervical Cancer Diagnostic Testing Market, by Service Provider – Revenue and Forecast to 2028 (USD Million)
Table 6. South Africa Cervical Cancer Diagnostic Testing Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 7. South Africa Cervical Cancer Diagnostic Testing Market, by Service Provider – Revenue and Forecast to 2028 (USD Million)
Table 8. Rest of MEA Cervical Cancer Diagnostic Testing Market, by Vaccines Type– Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of MEA Cervical Cancer Diagnostic Testing Market, by Service Provider – Revenue and Forecast to 2028 (USD Million)
Table 10. Organic Developments
Table 11. Inorganic Developments
Table 12. Glossary of Terms
LIST OF FIGURES
Figure 1. MEA Cervical Cancer Diagnostic Testing Market Segmentation
Figure 2. MEA Cervical Cancer Diagnostic Testing Market, By Country
Figure 3. MEA Cervical Cancer Diagnostic Testing Market Overview
Figure 4. PAP Testing Segment Held Largest Share of the Market in 2021
Figure 5. South Africa is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. MEA: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints Pertaining to MEA Cervical Cancer Diagnostic Testing Market
Figure 9. MEA Cervical Cancer Diagnostic Testing Market Forecast to 2028
Figure 10. MEA Cervical Cancer Diagnostic Testing Market, by Type, 2021 & 2028 (%)
Figure 11. MEA Pap Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. MEA HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. MEA Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. MEA Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. MEA Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. MEA Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. MEA Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)
Figure 18. MEA Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. MEA Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. MEA Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. MEA Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. MEA: Cervical Cancer Diagnostic Testing Market, by Key Country – Revenue (2021) (USD Million)
Figure 23. MEA: Cervical Cancer Diagnostic Testing Market, by Country, 2021 & 2028 (%)
Figure 24. Saudi Arabia: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. UAE: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. South Africa: Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Rest of MEA: Cervical Cancer Diagnostic Testing Market - Revenue and Forecast to 2028 (USD Million)
Figure 28. Impact of COVID-19 Pandemic on Cervical cancer diagnostics testing Market in MEA Countries
- Abbott
- BD
- Cooper Companies, Inc.
- F. Hoffmann-La Roche Ltd.
- Femasys Inc.
- Guided Therapeutics, Inc
- Hologic, Inc.
- QIAGEN
- Quest Diagnostics Incorporated
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For